obsessive-compulsive%20disorder
OBSESSIVE-COMPULSIVE DISORDER
Obsessive-compulsive disorder is characterized by the presence of either obsessions or compulsions, but more commonly by both symptoms that can cause marked impairment or distress.
Obsession is a recurrent, persistent, intrusive, unwanted thought, image or urge that cause distressing emotions (eg anxiety and disgust).
Compulsion is a repetitive behavior or mental act that the person feels driven to perform, in order to lessen the distress caused by the obsession.
Anxiety is the central feature of obsessive-compulsive disorder.
  1. Heyman I, Mataix-Cols D, Fineberg NA. Obsessive-compulsive disorder. BMJ. 2006 Aug;333(7565):424-429. PMID: 16931840
  2. March JS, Frances A, Carpenter D, et al. The Expert Consensus Guideline series: Treatment of obsessive-compulsive disorder. J Clin Psychiatry. 1997;58(Suppl 4):001-72
  3. Khouzam HR. Obsessive-Compulsive disorder. What to do if you recognize baffling behavior?. Postgrad Med. 1999 Dec;106(7):133-141. PMID: 10608970
  4. Stein DJ. Obsessive-compulsive disorder. Lancet. 2002 Aug;360(9330):397-405. PMID: 12241794
  5. Stein DJ, Denys D, Gloster AT, et al. Obsessive-compulsive disorder: diagnostic treatment issues. Psychiatr Clin North Am. 2009 Sep;32(3):665-685. PMID: 19716996
  6. MedWorm http://www.medworm.com/rss/index.php/Psychiatry/172/ www.medworm.com/rss/medicalfeeds/specialities/Psychiatry-News.xml
  7. Malaysian Psychiatric Association. Articles on psychiatry of public interest. Obsessive-compulsive disorder. http://www.psychiatry-malaysia.org/html/ocd.shtml
  8. World Health Organization. International classification of diseases and related health problems. 10th rev. WHO. http://www.who.int/classifications/apps/icd/icd10online. 2007
  9. National Institute of Mental Health. Obsessive-compulsive disorder. 2001
  10. Ciechanowski P, Katon W. Obsessive-compulsive disorder: epidemiology, clinical manifestations, and diagnosis. UpToDate. http://www.uptodate.com/contents/obsessive-compulsive-disorder-in-adults-epidemiology-pathogenesis-clinical-manifestations-course-and-diagnosis. 07 Feb 2011. Accessed 11 Oct 2011
  11. National Institute for Health and Care Excellence. Obsessive-compulsive disorder: core interventions in the treatment of obsessive-compulsive disorder and body dysmorphic disorder. CG 31. NICE. http://www.nice.org.uk/CG031. 2006
  12. American Psychiatric Association. Practice guideline for the treatment of patients with obsessive-compulsive disorder. Psychiatryonline. http://psychiatryonline.org/content.aspx?bookID=28§ionID=1678180. 2007.
  13. Ciechanowski P, Katon W. Pharmacotherapy for obsessive-compulsive disorder. UpToDate. http://www.uptodate.com/contents/pharmacotherapy-for-obsessive-compulsive-disorder. 18 Feb 2011. Accessed 11 Oct 2011
  14. Abramowitz J. Psychotherapy for obsessive-compulsive disorder. UpToDate. http://www.uptodate.com. Mar 2019. Accessed 11 Oct 2011.
  15. American Psychiatric Association. Obsessive-compulsive and related disorders. In: Diagnostic and statistical manual of mental disorders. 5th ed. Arlington, VA: American Psychiatric Publishing; 2013:237.
  16. Koran LM, Simpson HB. Guideline watch (March 2013): American Psychiatric Association (APA) practice guideline for the treatment of patients with obsessive-compulsive disorder. Psychiatryonline. http://psychiatryonline.org/content.aspx?bookid=28§ionid=40634994.
  17. Ministry of Health Singapore. Clinical practice guidelines anxiety disorders. MOH Singapore. http://www.moh.gov.sg/cpg. 2015 Jan.
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Psychiatry - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
3 days ago
Children with high dental anxiety are more likely to develop dental diseases, which, in turn, negatively affect the family’s quality of life, a recent study has found.
2 days ago
Exposure to corticosteroids in patients with autoimmune hepatitis (AIH) appears to contribute to increased risks of cataract, diabetes and bone fractures, a study has found. Notably, the fracture risk is elevated at low doses, while the risk of adverse events overall is dose-dependent and is reversible.
6 days ago
In patients with atrial fibrillation (AF) and stable coronary artery disease (CAD), rivaroxaban monotherapy is noninferior to combination treatment with an antiplatelet therapy in terms of cutting the risk of cardiovascular events and mortality, according to data from the AFIRE trial.
3 days ago
Supplementation with oral nano vitamin D appears to moderate disease activity and severity grade of patients with active ulcerative colitis (UC), suggests a study, adding that this association is more evident in those achieving a target vitamin D level of 40 ng/mL.